| View |
|
DRP-2479-06
|
Trimetazidine Hydrochloride
|
Retatrime
|
35 mg
|
Modified Release Film-Coated Tablet
|
Anti-anginal
|
Zim Laboratories Ltd
|
India
|
CLIDP Conversion
|
24 June 2024
|
23 September 2025
|
| View |
|
DRP-3590-08
|
Omeprazole (as Sodium)
|
Life-Zol
|
40 mg
|
Powder for Injection (IV)
|
Proton Pump Inhibitors
|
CSPC Ouyi Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
18 June 2024
|
14 July 2028
|
| View |
|
DRP-3651-06
|
Clarithromycin
|
None
|
250 mg/5 mL
|
Powder for Suspension
|
Antibacterial (Macrolide)
|
Ind-Swift Limited
|
India
|
CLIDP Conversion
|
24 June 2024
|
16 December 2027
|
| View |
|
DRP-4496-10
|
Mefenamic Acid
|
Mepel
|
500 mg
|
Tablet
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
24 June 2024
|
02 July 2028
|
| View |
|
DRP-4649-04
|
Glimepiride
|
Gliped
|
2 mg
|
Tablet
|
Blood Glucose-Lowering Drug (Sulfonylureas)
|
Lifesquare Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
24 June 2024
|
06 September 2025
|
| View |
|
DRP-4742-03
|
Montelukast (as Sodium)
|
Monlastik
|
10 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist
|
Flamingo Pharmaceuticals Ltd
|
India
|
CLIDP Conversion
|
18 June 2024
|
20 January 2027
|
| View |
|
DRP-4832-01
|
Paracetamol + Phenylephrine Hydrochloride + Chlorphenamine Maleate
|
Eracop
|
500 mg/10 mg /2 mg
|
Film-Coated Tablet
|
Nasal Decongestant/ Antihistamine/ Analgesic/ Antipyretic
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
30 June 2024
|
16 October 2028
|
| View |
|
DRP-5051-07
|
Azithromycin (as dihydrate)
|
None
|
200 mg/ 5 mL
|
Powder for Suspension
|
Antibacterial (Macrolide)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
23 June 2024
|
10 June 2028
|
| View |
|
DRP-5137-07
|
Atorvastatin (as calcium)
|
None
|
40 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitors
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 June 2024
|
13 February 2029
|
| View |
|
DRP-5362-27
|
Acetylcysteine
|
Zaecys
|
600 mg
|
Powder for Oral Solution
|
Mucolytic
|
Unicure Remedies Pvt. Ltd.
|
India
|
CLIDP Conversion
|
23 June 2024
|
25 June 2029
|
| View |
|
DRP-5762-04
|
Ambroxol Hydrochloride
|
Broxygen
|
15mg/5mL
|
Syrup (Cherry Flavor)
|
Mucolytic
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
18 June 2024
|
10 October 2027
|
| View |
|
DRP-5769-11
|
Gliclazide
|
Glizen 30
|
30 mg
|
Modified-Release Tablet
|
Oral Hypoglycemic Agent
|
Bal Pharma Ltd.
|
India
|
CLIDP Conversion
|
24 June 2024
|
13 June 2029
|
| View |
|
DRP-5926-11
|
Cefixime (as Trihydrate)
|
CefiPro
|
100 mg / 5mL
|
Powder for Suspension
|
Antibacterial (Cephalosporin)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
23 June 2024
|
12 October 2026
|
| View |
|
DRP-6028-03
|
Rabeprazole Sodium
|
Promizole
|
20 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Ravian Life Science Pvt. Ltd
|
India
|
CLIDP Conversion
|
23 June 2024
|
26 February 2025
|
| View |
|
DRP-6635-07
|
Pantoprazole (as sodium)
|
Pantoxac
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Brawn Laboratories Limited
|
India
|
CLIDP Conversion
|
23 June 2024
|
08 April 2026
|
| View |
|
DRP-6675-04
|
Paracetamol + Phenylephrine Hydrochloride + Chlorphenamine Maleate
|
Neopel
|
500 mg/ 10 mg/ 2 mg
|
Tablet
|
Analgesic/ Antipyretic/ Decongestant/ Antihistamine
|
Azarias Pharmaceuticals Laboratories,Inc
|
Philippines
|
CLIDP Conversion
|
30 June 2024
|
19 May 2026
|
| View |
|
DRP-6696-01
|
Glimepiride + Metformin hydrochloride
|
None
|
2 mg/500 mg
|
Extended-Release Tablet
|
Oral Hypoglycemic
|
Innova Captab Limited
|
India
|
CLIDP Conversion
|
19 June 2024
|
26 March 2029
|
| View |
|
DRP-6810-14
|
Co-Amoxiclav
|
Paxiclav
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin-Beta-Lactamase Inhibitor Combination)
|
Uni Medicolabs
|
India
|
CLIDP Conversion
|
23 June 2024
|
26 August 2026
|
| View |
|
DRP-7162-02
|
Prednisolone Sodium Phosphate
|
Prednizole
|
15 mg / 5 mL
|
Syrup
|
Corticosteroid
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
16 June 2024
|
10 November 2028
|
| View |
|
DRP-7343-08
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Elpitaz
|
4 g/500 mg
|
Powder for Injection (IV Infusion)
|
Penicillins
|
Uni Medicolabs
|
India
|
CLIDP Conversion
|
24 June 2024
|
19 September 2027
|